Suppr超能文献

早期激素受体阳性乳腺癌中通过自动数字免疫组织化学分析评估瘤内异质性和免疫反应特征的独立预后价值

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.

作者信息

Zilenaite Dovile, Rasmusson Allan, Augulis Renaldas, Besusparis Justinas, Laurinaviciene Aida, Plancoulaine Benoit, Ostapenko Valerijus, Laurinavicius Arvydas

机构信息

Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.

National Centre of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania.

出版信息

Front Oncol. 2020 Jun 16;10:950. doi: 10.3389/fonc.2020.00950. eCollection 2020.

Abstract

Immunohistochemistry (IHC) for ER, PR, HER2, and Ki67 is used to predict outcome and therapy response in breast cancer patients. The current IHC assessment, visual or digital, is based mostly on global biomarker expression levels in the tissue sample. In our study, we explored the prognostic value of digital image analysis of conventional breast cancer IHC biomarkers supplemented with their intratumoral heterogeneity and tissue immune response indicators. Surgically excised tumor samples from 101 female patients with hormone receptor-positive breast cancer (HRBC) were stained for ER, PR, HER2, Ki67, SATB1, CD8, and scanned at 20x. Digital image analysis was performed using the HALO™ platform. Subsequently, hexagonal tiling was used to compute intratumoral heterogeneity indicators for ER, PR and Ki67 expression. Multiple Cox regression analysis revealed three independent predictors of the patient's overall survival: Haralick's texture entropy of PR ( = 0.19, = 0.0005), Ki67 Ashman's D bimodality ( = 3.0, = 0.01), and CD8+SATB1+ cell density in tumor tissue ( = 0.32, = 0.02). Remarkably, the PR and Ki67 intratumoral heterogeneity indicators were prognostically more informative than the rates of their expression. In particular, a distinct non-linear relationship between the rate of PR expression and its intratumoral heterogeneity was observed and revealed a non-linear prognostic effect of PR expression. The independent prognostic significance of CD8+SATB1+ cells infiltrating the tumor could indicate their role in anti-tumor immunity. In conclusion, we suggest that prognostic modeling, based entirely on the computational image-based IHC biomarkers, is possible in HRBC patients. The intratumoral heterogeneity and immune response indicators outperformed both conventional breast cancer IHC and clinicopathological variables while markedly increasing the power of the model.

摘要

雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)和Ki67的免疫组织化学(IHC)检测用于预测乳腺癌患者的预后及治疗反应。目前的免疫组化评估,无论是视觉评估还是数字评估,大多基于组织样本中的整体生物标志物表达水平。在我们的研究中,我们探讨了对传统乳腺癌免疫组化生物标志物进行数字图像分析,并辅以肿瘤内异质性和组织免疫反应指标的预后价值。对101例激素受体阳性乳腺癌(HRBC)女性患者手术切除的肿瘤样本进行ER、PR、HER2、Ki67、SATB1、CD8染色,并以20倍放大倍数扫描。使用HALO™平台进行数字图像分析。随后,采用六边形平铺法计算ER、PR和Ki67表达的肿瘤内异质性指标。多因素Cox回归分析显示了患者总生存的三个独立预测因素:PR的哈拉里克纹理熵(P = 0.19,P = 0.0005)、Ki67的阿什曼双峰性(P = 3.0,P = 0.01)以及肿瘤组织中CD8 + SATB1 +细胞密度(P = 0.32,P = 0.02)。值得注意的是,PR和Ki67的肿瘤内异质性指标在预后方面比其表达率更具信息价值。特别是,观察到PR表达率与其肿瘤内异质性之间存在明显的非线性关系,并揭示了PR表达的非线性预后效应。浸润肿瘤的CD8 + SATB1 +细胞的独立预后意义可能表明它们在抗肿瘤免疫中的作用。总之,我们认为在HRBC患者中完全基于基于图像计算的免疫组化生物标志物进行预后建模是可行的。肿瘤内异质性和免疫反应指标优于传统的乳腺癌免疫组化和临床病理变量,同时显著提高了模型的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ae7/7308549/30afb7102482/fonc-10-00950-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验